论文部分内容阅读
目的:探讨儿科重症肺炎的临床治疗方法及效果。方法:对我院2013年12月~2014年12月收治的74例重症肺炎患儿采用回顾性分析。结果:观察组的退烧时间、啰音消失时间、并发症控制时间、咳嗽缓解时间、住院时间分别为3.2±0.3d、4.3±0.1d、3.2±0.2d、2.8±0.5d、10.2±1.3d,明显低于对照组,差异均有统计学意义(P均<0.05)。结论:基础治疗加用丙种球蛋白,可以有效改善其身体状况,提高患儿的抗病能力,减少患儿的并发症发生率,具有临床应用价值。
Objective: To explore the clinical treatment of pediatric severe pneumonia and its effects. Methods: A retrospective analysis was performed on 74 children with severe pneumonia admitted from December 2013 to December 2014 in our hospital. Results: The antipyretic time, rales disappearance time, complication control time, cough relief time and hospital stay in the observation group were respectively 3.2 ± 0.3d, 4.3 ± 0.1d, 3.2 ± 0.2d, 2.8 ± 0.5d, 10.2 ± 1.3d , Significantly lower than the control group, the difference was statistically significant (P all <0.05). Conclusion: The basic treatment plus gamma globulin can effectively improve their physical condition, improve children’s disease resistance and reduce the incidence of complications in children with clinical value.